Custom Enquiry
We aim to give you a response from a qualified scientist within a hour.
Product Details
Formula
C21H28N6O2
MW
396.5
Purity
>95%
Solubility (DMSO Mg/MI)
20
Storage (Powder)
3 Years -20°C
Storage (Solvent)
1 Year -80°C
Indication
Solid Tumors and Solid Neoplasm
Mode Of Action
Inhibitor
Drug Status
Discontinued
Target Name
Cyclin-dependent kinase 1 (CDK1)/Cyclin-dependent kinase 2 (CDK2)/Cyclin-dependent kinase 9 (CDK9)
Research Area
CANCER
Research Area Sub Group
Anticancer
Pharmacology
ENZYMES
Pharmacology Area Sub Group
Kinase
Bio Chemical Notes
Dinaciclib has been used in trials studying the treatment of rrMM, rrCLL, rrDLBCL, Solid Tumors, and Solid Neoplasm, among others.